PsychoGenics’ Announcements
Click on any Announcement for a complete description.
- PsychoGenics offers rodent primary neurons in culture
- PsychoGenics offers electrophysiological assessments of Hippocampal Long-Term Potentiation (LTP)
- PsychoGenics and Biotrofix offer Stroke, Traumatic Brain Injury, and Vascular Disease Models
- PsychoGenics offers high throughput drug screening using the SmartCube® System
- PsychoGenics and Afraxis offer Dendritic Spine Analysis
- PsychoGenics Offers assays For Distinct Impulsivity Types
- PsychoGenics offers quantification of phosphoproteins and other post-translational modifications
- Neurodevelopmental Schizophrenia Model
- Models of Duchennes Muscular Dystrophy
- Traumatic Brain Injury Model
- Huntington Disease Models
- Spinal Cord Injury Model
- Mouse Models of Spinal Muscular Atrophy
- PsychoGenics Offers a Battery of Drug Abuse Liability Assays
- PsychoGenics' Pain Capabilities
- Announcing Faster, More Efficient In Vivo Neurogenesis Capabilities
- PsychoGenics Expands Microdialysis Capabilities
- Electrophysiology Customization to Suit Your Drug Discovery Needs
